Suitability of allogeneic sertoli cells for ex vivo gene delivery in the injured spinal cord

Experimental Neurology

Volumn 198, Issue 1, 2006, Pages 88-100

  Trivedi, Alpa A ^a   Igarashi, Takuji ^b   Compagnone, Nathalie ^b   Fan, Xiaoqing ^a   Hsu, Jung Yu C ^b   Hall, Deborah E ^a   John, Constance M ^a   Noble Haeusslein, Linda J ^b  

^a MandalMed Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Gene therapy; Inflammation; Neurotrophin 3; Sertoli cells; Spinal cord injury

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; NEUROTROPHIN 3;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL BASED GENE THERAPY; CELL FUNCTION; CELL SURVIVAL; CONTROLLED STUDY; DNA MODIFICATION; EMBRYO; EX VIVO STUDY; GENE TARGETING; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SERTOLI CELL; SPINAL CORD INJURY; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, CD11B; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYO; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; LYMPHOCYTES; MALE; MICE; NERVE REGENERATION; NEUROTROPHIN 3; SERTOLI CELLS; SPINAL CORD INJURIES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 32644434552     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.11.009     Document Type: Article

References (59)

1. R.D. Anderson, R.E. Haskell, H. Xia, B.J. Roessler, and B.L. Davidson A simple method for the rapid generation of recombinant adenovirus vectors Gene Ther. 7 12 2000 1034 1038
2. C.F. Barker, and R.E. Billingham Immunologically privileged sites Adv. Immunol. 25 1977 1 54
3. B. Bartosch, and F. Cosset Strategies for retargeted gene delivery using vectors derived from lentiviruses Curr. Gene Ther. 4 4 2004 427 443
4. M.S. Beattie, J.C. Bresnahan, J. Komon, C.A. Tovar, M. Van Meter, D.K. Anderson, A.I. Faden, C.Y. Hsu, L.J. Noble, S. Salzman, and W. Young Endogenous repair after spinal cord contusion injuries in the rat Exp. Neurol. 148 2 1997 453 463
5. M. Beattie, Q. Li, and J. Bresnahan Cell death and plasticity after experimental spinal cord injury Prog. Brain Res. 128 2000 9 21
6. E. Becker, R.M. Soler, V.J. Yuste, E. Gine, C. Sanz-Rodriguez, J. Egea, D. Martin-Zanca, and J.X. Comella Development of survival responsiveness to brain-derived neurotrophic factor, neurotrophin 3 and neurotrophin 4/5, but not to nerve growth factor, in cultured motoneurons from chick embryo spinal cord J. Neurosci. 18 19 1998 7903 7911
7. D. Bellgrau, D. Gold, H. Selawry, J. Moore, F.A. Franzusof, and R.C. Duke A role for CD95 ligand in preventing graft rejection Nature 377 6550 1995 630 632
8. A. Blesch, R.J. Grill, and M.H. Tuszynski Neurotrophin gene therapy in CNS models of trauma and degeneration Prog. Brain Res. 117 1998 473 484
9. A.R. Blight Effects of silica on the outcome from experimental spinal cord injury: implication of macrophages in secondary tissue damage Neuroscience 60 1 1994 263 273
10. B.S. Bregman Regeneration in the spinal cord Curr. Opin. Neurobiol. 8 6 1998 800 807
11. S. Brenner, and H. Malech Current developments in the design of onco-retrovirus and lentivirus vector systems for hematopoietic cell gene therapy Biochim. Biophys. Acta 1640 1 2003 1 24
12. J.C. Bresnahan, M.S. Beattie, F.D. Todd III, and D.H. Noyes A behavioral and anatomical analysis of spinal cord injury produced by a feedback-controlled impaction device Exp. Neurol. 95 3 1987 548 570
13. A. Brooks, R. Harkins, P. Wang, H. Qian, P. Liu, and G. Rubanyi Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle J. Gene Med. 6 4 2004 395 404
14. R. Bunge, W. Puckett, J. Becerra, A. Marcillo, and R. Quencher Observations on the pathology of human spinal cord injury: a review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination Adv. Neurol. 1993 75 78
15. C. Campbell, S. Hultman, B. Cairns, S. DeSerres, and A. Meyer Green fluorescent protein-adenoviral construct as a model for transient gene therapy for human cultured keratinocytes in an athymic mouse model J. Trauma 54 1 2003 72 80
16. N.A. Compagnone, and S.H. Mellon Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development Proc. Natl. Acad. Sci. U. S. A. 95 8 1998 4678 4683
17. J.V. Coumans, T.T. Lin, H.N. Dai, L. MacArthur, M. McAtee, C. Nash, and B.S. Bregman Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins J. Neurosci. 21 23 2001 9334 9344
18. S. David, and S. Lacroix Molecular approaches to spinal cord repair Annu. Rev. Neurosci. 26 2003 411 440
19. P. De Cesaris, A. Filippini, C. Cervelli, A. Riccioli, S. Muci, G. Starace, M. Stefanini, and E. Ziparo Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes Biochem. Biophys. Res. Commun. 186 3 1992 1639 1646
20. B. De Geest, S. Van Linthout, and D. Collen Sustained expression of human apo A-I following adenoviral gene transfer in mice Gene Ther. 8 2 2001 121 127
21. J. Dufour, R. Rajotte, K. Seeberger, T. Kin, and G. Korbutt Long-term survival of neonatal porcine Sertoli cells in non-immunosuppressed rats Xenotransplantation 10 6 2003 577 586
22. J.M. Dufour, R. Hemendinger, C.R. Halberstadt, P. Gores, D.F. Emerich, G.S. Korbutt, and R.V. Rajotte Genetically engineered Sertoli cells are able to survive allogeneic transplantation Gene Ther. 11 8 2004 694 700
23. R. Gotz, R. Kolbeck, F. Lottspeich, and Y.A. Barde Production and characterization of recombinant mouse neurotrophin-3 Eur. J. Biochem. 204 2 1992 745 749
24. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt, M.P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C.S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J.I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L.E. Leiva, M. Wissler, C. Prinz, T.H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 Science 302 5644 2003 415 419
25. M. Hedger The testis: an 'immunologically suppressed' tissue? Reprod. Fertil. Dev. 1 1 1989 9 75
26. F. Hefti Neurotrophic factor therapy for nervous system degenerative diseases J. Neurobiol. 25 11 1994 1418 1435
27. D.A. Houweling, A.J. Lankhorst, W.H. Gispen, P.R. Bar, and E.A. Joosten Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery Exp. Neurol. 153 1 1998 49 59
28. L.L. Jones, M. Oudega, M.B. Bunge, and M.H. Tuszynski Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury J. Physiol. 533 Pt. 1 2001 83 89
29. C. Kalcheim, C. Carmeli, and A. Rosenthal Neurotrophin 3 is a mitogen for cultured neural crest cells Proc. Natl. Acad. Sci. U. S. A. 89 5 1992 1661 1665
30. G.S. Korbutt, J.F. Elliott, and R.V. Rajotte Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression Diabetes 46 2 1997 317 322
31. A.M. Lever, P.M. Strappe, and J. Zhao Lentiviral vectors J. Biomed. Sci. 11 4 2004 439 449
32. X.Z. Liu, X.M. Xu, R. Hu, C. Du, S.X. Zhang, J.W. McDonald, H.X. Dong, Y.J. Wu, G.S. Fan, M.F. Jacquin, C.Y. Hsu, and D.W. Choi Neuronal and glial apoptosis after traumatic spinal cord injury J. Neurosci. 17 14 1997 5395 5406
33. A. Logan, and M. Berry Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS Trends Pharmacol. Sci. 14 9 1993 337 342
34. P.J. Mabon, L.C. Weaver, and G.A. Dekaban Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment Exp. Neurol. 166 1 2000 52 64
35. J.W. McDonald Repairing the damaged spinal cord Sci. Am. 281 3 1999 64 73
36. D.M. McTigue, P.G. Popovich, L.B. Jakeman, and B.T. Stokes Strategies for spinal cord injury repair Prog. Brain Res. 128 2000 3 8
37. L.J. Noble, and J.R. Wrathall Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord Exp. Neurol. 88 1 1985 135 149
38. L.J. Noble, and J.R. Wrathall Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat Exp. Neurol. 103 1 1989 34 40
39. L. Noble, F. Donovan, T. Igarashi, S. Goussev, and Z. Werb Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events J. Neurosci. 22 17 2002 7526 7535
40. D. Persons, and J. Tisdale Gene therapy for the hemoglobin disorders Semin. Hematol. 41 4 2004 279 286
41. P.G. Popovich, Z. Guan, P. Wei, I. Huitinga, N. van Rooijen, and B.T. Stokes Depletion of hematogenous macrophages promotes partial hindlimb recovery and neuroanatomical repair after experimental spinal cord injury Exp. Neurol. 158 2 1999 351 365
42. G. Romano, P. Michell, C. Pacilio, and A. Giordano Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications Stem Cells 18 1 2000 19 39
43. M. Rosenzweig, M. Connole, R. Glickman, S. Yue, B. Noren, M. DeMaria, and R. Johnson Induction of cytotoxic T lymphocyte and antibody responses to enhanced green fluorescent protein following transplantation of transduced CD34(+) hematopoietic cells Blood 97 7 2001 1951 1959
44. M.J. Ruitenberg, G.W. Plant, F.P. Hamers, J. Wortel, B. Blits, P.A. Dijkhuizen, W.H. Gispen, G.J. Boer, and J. Verhaagen Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord J. Neurosci. 23 18 2003 7045 7058
45. P.R. Sanberg, A.I. Othberg, C.V. Borlongan, S. Saporta, A. Anton, T.B. Freeman, D.W. Cahill, R.C. Allen, and D.F. Cameron Transplantation of testis-derived Sertoli cells into the mammalian brain Transplant. Proc. 29 4 1997 1926 1928
46. S. Saporta, D.F. Cameron, C.V. Borlongan, and P.R. Sanberg Survival of rat and porcine Sertoli cell transplants in the rat striatum without cyclosporine-A immunosuppression Exp. Neurol. 146 2 1997 299 304
47. L. Schnell, R. Schneider, R. Kolbeck, Y.A. Barde, and M.E. Schwab Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion Nature 367 6459 1994 170 173
48. H.P. Selawry, and D.F. Cameron Sertoli cell-enriched fractions in successful islet cell transplantation Cell Transplant 2 2 1993 123 129
49. H.P. Selawry, M. Kotb, H.G. Herrod, and Z.N. Lu Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site Transplantation 52 5 1991 846 850
50. M. Senut, M.H. Tuszynski, H.K. Raymon, S.H. Suhr, N.H. Liou, K.R. Jones, L.F. Reichardt, and F.H. Gage Regional differences in responsiveness of adult CNS axons to grafts of cells expressing human neurotrophin 3 Exp. Neurol. 135 1 1995 36 55
51. T.A. Smith, M.G. Mehaffey, D.B. Kayda, J.M. Saunders, S. Yei, B.C. Trapnell, A. McClelland, and M. Kaleko Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice Nat. Genet. 5 4 1993 397 402
52. J. Streilein Unraveling immune privilege Science 270 5239 1995 1158 1159
53. R. Stripecke, M. Carmen Villacres, D. Skelton, N. Satake, S. Halene, and D. Kohn Immune response to green fluorescent protein: implications for gene therapy Gene Ther. 6 7 1999 1305 1312
54. W. Suarez-Pinzon, G.S. Korbutt, R. Power, J. Hooton, R.V. Rajotte, and A. Rabinovitch Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism Diabetes 49 11 2000 1810 1818
55. Y. Taoka, and K. Okajima Spinal cord injury in the rat Prog. Neurobiol. 56 3 1998 341 358
56. C.A. Tobias, J.S. Shumsky, M. Shibata, M.H. Tuszynski, I. Fischer, A. Tessler, and M. Murray Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration Exp. Neurol. 184 1 2003 97 113
57. P.J. Turek, S.B. Malkowicz, J.E. Tomaszewski, A.J. Wein, and D. Peehl The role of the Sertoli cell in active immunosuppression in the human testis Br. J. Urol. 77 6 1996 891 895
58. M.H. Tuszynski, R. Grill, L.L. Jones, A. Brant, A. Blesch, K. Low, S. Lacroix, and P. Lu NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection Exp. Neurol. 181 2003 47 56
59. A.E. Willing, A.I. Othberg, S. Saporta, A. Anton, S. Sinibaldi, S.G. Poulos, D.F. Cameron, T.B. Freeman, and P.R. Sanberg Sertoli cells enhance the survival of co-transplanted dopamine neurons Brain Res. 822 1-2 1999 246 250